TrialJournal of neurology, neurosurgery, and psychiatry2019

Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis.

Peter J Goadsby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.